For more information on our studies call 1-888-819-0004
ENGINE
Assesses youth, age 14-17, with moderate to severe, and untreated major depressive disorder using current state of the art measures of depression: standardized and validated clinical rating scales. The same measures will be completed age and gender matched healthy youth. Adolescents who meet criteria will be treated by using SSRIs and a brief, psychosocial intervention. We are no longer recruiting for this study.
CAE Effectiveness Study
Customized Adherence Enhancement (CAE) is a brief, practical Bipolar Disorder-specific approach that identifies individual patient adherence barriers and then targets these areas for intervention using a flexibly administered modular format.
CAE ADHD
This 3-phase project will characterize the needs of AYAs with ADHD, refine the CAE curriculum, and preliminary test the intervention on treatment adherence and reduction in substance use risk.
iTAB-CV
A personalized patient-centered adherence intervention iTAB-CV + Self-Monitoring (iTAB-CV + SM) vs. Self-Monitoring (SM) alone in poorly adherent hypertensive persons with bipolar disorder. The observation duration will be 12 months. Click here for more information.
IGNITE: AYA-CAE
To find out if an educational and behavioral intervention, called Customized Adherence Enhancement for Adolescents and Young Adults (CAE-AYA), helps patients with taking their medication and missing fewer doses compared to a standard educational program about bipolar disorder. Click here for more information.
TEAM 2
To find out if a group educational and behavioral intervention, called TargetEd MAnageMent Intervention (TEAM), helps African-American men with reducing their stroke risk factors. The TEAM approach is intended to reduce the unacceptably high rates of stroke and stroke complications in African-American (AA) men who have experienced mild deficit stroke or transient ischemic attack (TIA, mini-stroke). Click here for more information.
SMART 2.0
In collaboration with the University of Iowa, SMART is a RCT for adults with sub-optimally controlled epilepsy. It is a virtually delivered educational and behavioral intervention intended to enhance epilepsy self-management in rural/sub rural populations. Click here for more information.
SMART 3.0
Epilepsy self-management program delivered by a coalition of partners dedicated to supporting the multi-dimensional needs of individuals with epilepsy. SMART is delivered in collaboration with the Epilepsy Association of Western and Central PA, Epilepsy Association, and Epilepsy Alliance Ohio to increase the availability and accessibility of resources for people with epilepsy in Ohio, Pennsylvania, West Virginia, and Kentucky. Click here for more information.
Caregiver Research to Understand Factors Affecting Sleep and Cardiovascular Health
research team led by Dr. Elliane Irani at the Frances Payne Bolton School of Nursing is currently recruiting African American family caregivers to understand the factors that affect their caregiving experience, sleep, and cardiovascular health. This project is being conducted by Dr. Elliane Irani and her team, in collaboration with their community partners, Fairhill Partners and McGregor PACE. Click here for more information.
CADRC
The Cleveland Alzheimer’s Disease Research Center (CADRC) aims to study the different forms of dementia in the hope that learning more about the disease can lead to new forms of treating, and eventually curing, Alzheimer’s and related disorders. The CADRC will follow individuals over time collecting clinical information, specimens, and imaging data for future research. We not only will be enrolling individuals with memory problems, such as those diagnosed with Alzheimer’s disease or Lewy body dementia, but we also want to follow healthy individuals over time. Click here for more information.
POWER
Examines a health communication approach to specifically target known barriers/facilitators among minorities with risk for cognitive impairment and uses a well-established behavioral change model to promote enhanced participation in Alzheimer's disease research. Click here for more information. Click here for more information.